vs
Side-by-side financial comparison of N-able, Inc. (NABL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
N-able, Inc. is the larger business by last-quarter revenue ($130.3M vs $75.5M, roughly 1.7× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.8%). N-able, Inc. produced more free cash flow last quarter ($20.9M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.0%).
Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NABL vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $130.3M | $75.5M |
| Net Profit | — | — |
| Gross Margin | 76.2% | 69.3% |
| Operating Margin | 10.2% | 22.7% |
| Net Margin | — | — |
| Revenue YoY | 11.8% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.04 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $130.3M | $75.5M | ||
| Q3 25 | $131.7M | $54.5M | ||
| Q2 25 | $131.2M | $52.4M | ||
| Q1 25 | $118.2M | $46.0M | ||
| Q4 24 | $116.5M | $59.1M | ||
| Q3 24 | $116.4M | $80.5M | ||
| Q2 24 | $119.4M | $47.1M | ||
| Q1 24 | $113.7M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $1.4M | $8.8M | ||
| Q2 25 | $-4.0M | $5.9M | ||
| Q1 25 | $-7.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $10.8M | $20.3M | ||
| Q2 24 | $9.5M | $-4.5M | ||
| Q1 24 | $7.5M | $-4.8M |
| Q4 25 | 76.2% | 69.3% | ||
| Q3 25 | 77.5% | 77.7% | ||
| Q2 25 | 78.1% | 76.5% | ||
| Q1 25 | 76.6% | 77.1% | ||
| Q4 24 | 80.0% | 76.4% | ||
| Q3 24 | 82.9% | 63.9% | ||
| Q2 24 | 84.0% | 77.4% | ||
| Q1 24 | 83.9% | 75.5% |
| Q4 25 | 10.2% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | 7.7% | 12.7% | ||
| Q1 25 | 1.5% | 8.7% | ||
| Q4 24 | 13.7% | 22.6% | ||
| Q3 24 | 20.5% | 27.4% | ||
| Q2 24 | 18.4% | -4.6% | ||
| Q1 24 | 18.0% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 16.2% | ||
| Q2 25 | -3.1% | 11.2% | ||
| Q1 25 | -6.1% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.2% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% | ||
| Q1 24 | 6.6% | -11.0% |
| Q4 25 | $-0.04 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $-0.02 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $0.06 | $0.41 | ||
| Q2 24 | $0.05 | $-0.09 | ||
| Q1 24 | $0.04 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.8M | $97.5M |
| Total DebtLower is stronger | $393.9M | $22.7M |
| Stockholders' EquityBook value | $804.7M | $130.3M |
| Total Assets | $1.4B | $216.3M |
| Debt / EquityLower = less leverage | 0.49× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.8M | $97.5M | ||
| Q3 25 | $101.4M | $94.4M | ||
| Q2 25 | $93.9M | $96.0M | ||
| Q1 25 | $94.1M | $93.2M | ||
| Q4 24 | $85.2M | $101.0M | ||
| Q3 24 | $174.4M | $96.7M | ||
| Q2 24 | $157.5M | $96.8M | ||
| Q1 24 | $139.2M | $107.2M |
| Q4 25 | $393.9M | $22.7M | ||
| Q3 25 | $331.7M | $34.0M | ||
| Q2 25 | $332.1M | $45.3M | ||
| Q1 25 | $332.6M | $56.7M | ||
| Q4 24 | $333.1M | $68.0M | ||
| Q3 24 | $333.6M | $79.3M | ||
| Q2 24 | $334.1M | $90.7M | ||
| Q1 24 | $334.5M | $102.0M |
| Q4 25 | $804.7M | $130.3M | ||
| Q3 25 | $813.4M | $115.3M | ||
| Q2 25 | $809.4M | $104.7M | ||
| Q1 25 | $775.1M | $97.1M | ||
| Q4 24 | $759.3M | $92.1M | ||
| Q3 24 | $765.0M | $71.1M | ||
| Q2 24 | $724.4M | $48.5M | ||
| Q1 24 | $709.1M | $51.0M |
| Q4 25 | $1.4B | $216.3M | ||
| Q3 25 | $1.4B | $202.9M | ||
| Q2 25 | $1.4B | $194.9M | ||
| Q1 25 | $1.4B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
| Q4 25 | 0.49× | 0.17× | ||
| Q3 25 | 0.41× | 0.30× | ||
| Q2 25 | 0.41× | 0.43× | ||
| Q1 25 | 0.43× | 0.58× | ||
| Q4 24 | 0.44× | 0.74× | ||
| Q3 24 | 0.44× | 1.12× | ||
| Q2 24 | 0.46× | 1.87× | ||
| Q1 24 | 0.47× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | $14.4M |
| Free Cash FlowOCF − Capex | $20.9M | $14.4M |
| FCF MarginFCF / Revenue | 16.0% | 19.1% |
| Capex IntensityCapex / Revenue | 3.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.3M | $14.4M | ||
| Q3 25 | $24.0M | $9.7M | ||
| Q2 25 | $24.2M | $14.1M | ||
| Q1 25 | $19.7M | $3.6M | ||
| Q4 24 | $26.0M | $15.6M | ||
| Q3 24 | $22.0M | $11.0M | ||
| Q2 24 | $27.3M | $1.0M | ||
| Q1 24 | $4.2M | $11.2M |
| Q4 25 | $20.9M | $14.4M | ||
| Q3 25 | $17.4M | $9.7M | ||
| Q2 25 | $20.4M | $14.1M | ||
| Q1 25 | $16.4M | $3.6M | ||
| Q4 24 | $18.8M | $15.6M | ||
| Q3 24 | $18.2M | $11.0M | ||
| Q2 24 | $24.0M | $1.0M | ||
| Q1 24 | $746.0K | — |
| Q4 25 | 16.0% | 19.1% | ||
| Q3 25 | 13.2% | 17.7% | ||
| Q2 25 | 15.5% | 26.8% | ||
| Q1 25 | 13.9% | 7.7% | ||
| Q4 24 | 16.2% | 26.4% | ||
| Q3 24 | 15.7% | 13.7% | ||
| Q2 24 | 20.1% | 2.1% | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 3.4% | 0.0% | ||
| Q3 25 | 5.0% | 0.0% | ||
| Q2 25 | 2.9% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 6.1% | 0.0% | ||
| Q3 24 | 3.2% | 0.0% | ||
| Q2 24 | 2.7% | 0.0% | ||
| Q1 24 | 3.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 17.36× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.04× | 0.54× | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | 0.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
PBYI
Segment breakdown not available.
